CareRx Corporation

TSX:CRRX.TO

Medical - Care Facilities

Healthcare
$3.21 +0.63%

+$0.02 today

Market cap
$203.06M
Beta
0.62
P/E (TTM)
7.4
EPS (TTM)
$0.43
Dividend yield
1.88%
52W Low $2.70High $4.00

Volume 0.01M

Average 0.04M

CRRX.TO Net Income

Bottom-line profit, the starting point for calculating cash from operations.

CareRx CorporationTSX: CRRX.TO

Net Income · Q1 FY2026 · quarter ended Mar 2026

Net income grows, but more slowly than its trailing trend

Q1 FY2026 net income of CA$1.17M rose 415.0% year over year, behind the +820.5% change in trailing-twelve-month net income. Sequentially, it fell 95.1% from the prior quarter.

Context

  • Net income amounted to 7.1% of revenue in FY2025, up 5.8 pp from a year earlier.
  • Net income increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether net income reaches the consensus estimate from 6 analysts of CA$4.5M (-82.8%) for the fiscal year ending Dec 2026, a slowdown from the +680.5% reported in FY2025.

Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$1.17M-95.1% QoQ
Last fiscal yearDec 2025
CA$26.13M+680.5% YoY
LTMMar 2026
CA$27.07M+820.5% YoY
Net Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+415.0%+166.7%-248.3 pp
1 year+680.5%-82.8%-763.3 pp
3-year CAGR—-20.5%—
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Income history

CAD · from the cash flow

Latest · FY2025
26.13M CAD
Year-over-year change
+680.5%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Income vs competitors

How CRRX.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so net income is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +820.5% is the highest of 6, against a peer median of -42.7%.
  • Net income amounts to 7.2% of revenue for CRRX.TO, versus a peer median of 19.7%.
CRRX.TO Competitors
Net Income for CRRX.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
PRN.TOProfound Medical Corp.LTM Mar 2026$38.94M USD+20.4%+14.1%207.6%
XLY.TOAuxly Cannabis Group Inc.LTM Mar 2026CA$33.21M CAD+52.5%—20.9%
DR.TOMedical Facilities CorporationLTM Mar 2026$33.14M USD-68.8%+19.7%10.9%
CRRX.TOCareRx CorporationLTM Mar 2026CA$27.07M CAD+820.5%—7.2%
HLS.TOHLS Therapeutics Inc.LTM Mar 2026$10.31M USD-42.7%-19.2%18.5%
HBP.TOHelix BioPharma Corp.LTM Apr 2026CA$3.32M CAD-65.1%-7.4%—
Peer median (excluding CRRX.TO) —-42.7%+3.3%19.7%

Competitors are the stored peer set for CRRX.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

CAD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(22.73M)(34.35M)(5.41M)(4.5M)26.13M
Depreciation & Amortization15.39M20.07M19.98M19.19M18.33M
Deferred Income Tax(1.01M)(1.54M)(4.19M)32K(22.77M)
Stock-Based Compensation2.67M4.57M1.47M3.65M2.72M
Change in Working Capital(3.73M)638K2.12M8.98M(988K)
Accounts Receivables(11.72M)1.51M1.47M3.82M247K
Inventory(2.83M)(2M)648K1.55M(126K)
Accounts Payables15M816K(181K)3.46M(891K)
Other Working Capital(4.17M)307K186K145K(218K)
Other Non-Cash Items16.67M32.96M13.4M10.64M4.12M
Operating Cash Flow7.27M22.33M27.38M37.99M27.54M
Capital Expenditures(7.12M)(13.61M)(8.7M)(8.11M)(5.59M)
Acquisitions (Net)(86.13M)(2.99M)(3.66M)196K39K
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities67K(3.57M)(3.93M)(2.53M)0
Investing Cash Flow(93.18M)(16.6M)(12.31M)(7.92M)(8.26M)
Debt Repayment30.35M(5.29M)(39.82M)(21.58M)(4.32M)
Common Stock Issued80.86M1.01M14.68M014K
Common Stock Repurchased00(56K)(801K)(2.24M)
Dividends Paid0000(1.26M)
Other Financing Activities(9.3M)(8.71M)(11.2M)(5.64M)(6.64M)
Financing Cash Flow101.91M(12.99M)(36.4M)(28.02M)(14.44M)
Effect of Forex Changes00000
Net Change in Cash16M(7.25M)(21.34M)2.06M4.84M
Free Cash Flow153K8.72M18.68M29.88M21.95M

CareRx Corporation

TSX:CRRX.TO

Intrinsic Alpha fair value

Locked

Current Price

$3.21

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.